First National Bank of Omaha Sells 5,322 Shares of Revvity Inc. $RVTY

First National Bank of Omaha reduced its holdings in shares of Revvity Inc. (NYSE:RVTY) by 7.3% during the fourth quarter, Holdings Channel reports. The fund owned 68,062 shares of the company’s stock after selling 5,322 shares during the period. First National Bank of Omaha’s holdings in Revvity were worth $6,585,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Storgate LLC bought a new position in Revvity during the fourth quarter valued at approximately $367,000. Dynamic Technology Lab Private Ltd bought a new position in Revvity during the fourth quarter valued at approximately $807,000. Wells Fargo & Company MN grew its position in Revvity by 2.8% during the fourth quarter. Wells Fargo & Company MN now owns 64,800 shares of the company’s stock valued at $6,269,000 after acquiring an additional 1,749 shares during the last quarter. HRT Financial LP bought a new position in Revvity during the fourth quarter valued at approximately $3,951,000. Finally, Orion Porfolio Solutions LLC grew its position in Revvity by 86.0% during the fourth quarter. Orion Porfolio Solutions LLC now owns 5,233 shares of the company’s stock valued at $506,000 after acquiring an additional 2,419 shares during the last quarter. 86.65% of the stock is currently owned by institutional investors.

Revvity Stock Performance

Shares of RVTY stock opened at $99.66 on Friday. The stock has a fifty day moving average of $94.91 and a 200 day moving average of $97.75. Revvity Inc. has a 52 week low of $81.22 and a 52 week high of $118.30. The firm has a market capitalization of $11.12 billion, a price-to-earnings ratio of 47.68, a PEG ratio of 2.22 and a beta of 1.11. The company has a quick ratio of 1.41, a current ratio of 1.72 and a debt-to-equity ratio of 0.37.

Revvity (NYSE:RVTY) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $1.06 EPS for the quarter, topping analysts’ consensus estimates of $1.02 by $0.04. Revvity had a return on equity of 8.00% and a net margin of 8.26%.The company had revenue of $711.12 million during the quarter, compared to analyst estimates of $704.07 million. During the same quarter last year, the firm posted $1.01 earnings per share. The firm’s revenue was up 7.0% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. As a group, research analysts expect that Revvity Inc. will post 5.25 earnings per share for the current year.

Revvity Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Investors of record on Friday, July 17th will be paid a $0.07 dividend. The ex-dividend date of this dividend is Friday, July 17th. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. Revvity’s dividend payout ratio (DPR) is presently 13.40%.

Analysts Set New Price Targets

A number of research analysts have commented on RVTY shares. The Goldman Sachs Group reduced their price target on shares of Revvity from $110.00 to $95.00 and set a “neutral” rating on the stock in a research report on Tuesday, April 14th. Wolfe Research began coverage on Revvity in a research note on Tuesday, June 2nd. They set a “peer perform” rating for the company. Stifel Nicolaus dropped their price objective on Revvity from $110.00 to $100.00 and set a “hold” rating for the company in a research note on Wednesday, May 6th. TD Cowen increased their price objective on Revvity from $115.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. Finally, Wall Street Zen lowered Revvity from a “buy” rating to a “hold” rating in a research note on Saturday, April 18th. Four analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Revvity presently has an average rating of “Hold” and a consensus price target of $107.73.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.